Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-01

Clinical Trial Update: Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for FX006 in osteoarthritis of the knee; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FX006

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Osteoarthritis of the Knee | Phase 3 | Status: COMPLETED | Results posted: 2018-02-01